超声诊断在老年乳腺癌新辅助化疗患者病灶变化显示中的价值

发布时间：2018-03-05 01:40

  本文选题：超声诊断　切入点：乳腺癌　出处：《中国老年学杂志》2015年11期 　论文类型：期刊论文

【摘要】：目的探讨超声诊断对老年乳腺癌新辅助化疗患者病灶变化的显示价值。方法选择2013年5月至2014年5月在该院接受治疗的乳腺癌患者55例。化疗后依据WHO实体瘤疗效判定标准实施评价,其中化疗有效组38例,化疗无效组17例,对比治疗前后经超声诊断显示病灶变化,肿瘤内部血流分级情况以及不同组别肿瘤病灶血流动力学指标变化情况。结果超声显示新辅助化疗后患者病灶的长、宽、厚、面积及体积均显著少于新辅助化疗前的水平(均P0.05)。新辅助化疗后,患者肿瘤内部的血流分级以0~Ⅰ级为主,显著优于新辅助化疗前的Ⅱ~Ⅲ级(P0.05)。化疗无效组治疗前后的最高流速(Vmax)及阻力指数(RI)水平相比差异均无统计学意义(均P0.05)。化疗有效组治疗后的Vmax及RI水平均分别显著低于治疗前以及化疗无效组治疗后(均P0.05)。结论超声诊断能够客观地评价老年乳腺癌患者经过新辅助化疗治疗的病灶变化,对于后期治疗方案的进一步制定具有较大的辅助价值。
[Abstract]:Objective to investigate the value of ultrasonic diagnosis in the diagnosis of neoadjuvant chemotherapy in elderly patients with breast cancer. Methods 55 patients with breast cancer who were treated in our hospital from May 2013 to May 2014 were selected. After chemotherapy, 55 patients were treated with WHO solid tumor therapy. Evaluation of effectiveness criteria, There were 38 cases in the effective group of chemotherapy and 17 cases in the group of ineffective chemotherapy. Results Ultrasound showed the length, width and thickness of the lesions after neoadjuvant chemotherapy. The area and volume of neoadjuvant chemotherapy were significantly lower than those before neoadjuvant chemotherapy (P0.05). After neoadjuvant chemotherapy, the grade of blood flow in tumor was mainly grade 0 ~ 鈪，

本文编号：1568225